文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

围产期高剂量促红细胞生成素对极早产或超早产学龄期儿童视网膜功能的影响

The Effect of High-Dose Erythropoietin Perinatally on Retinal Function in School-Aged Children Born Extremely or Very Preterm.
PubMed 文献 · Am J Ophthalmol · 2024-07-10

本研究为随机双盲临床试验随访加队列研究,纳入7至15岁极早产或超早产儿童,比较围产期接受高剂量重组人促红细胞生成素(rhEPO)与安慰剂者的视网膜电图(ERG)参数。结果显示EPO组与安慰剂组ERG参数无差异(校正P均>.05),安慰剂组两项视锥系统介导的峰值时间较健康对照略慢,EPO组一项视杆系统为主的峰值时间较健康对照略快。结论认为围产期高剂量rhEPO对儿童期视网膜功能无可测影响。

要点

  • EPO组(n=52,104眼)与安慰剂组(n=35,70眼)ERG参数无差异,校正P均>.05。
  • 安慰剂组两项视锥系统介导峰值时间较健康对照略慢(系数0.53,95%CI 0.21-0.85;系数0.36,95%CI 0.13-0.60)。
  • EPO组一项视杆系统为主峰值时间较健康对照略快(系数-4.33,95%CI -6.88至-1.78)。

核心结论

  • 围产期给予极早产或超早产儿高剂量rhEPO,与安慰剂相比在儿童期对视网膜功能无可测影响。
  • 早产可能对儿童期视网膜功能造成小的、很可能无临床意义的影响,围产期给予rhEPO可能部分减轻该影响。

研究设计与样本

  • 随机双盲临床试验随访加队列研究,地点为瑞士苏黎世大学医院眼科。
  • 研究对象为7至15岁极早产或超早产儿童,既往围产期随机接受高剂量rhEPO或安慰剂。
  • 纳入标准为参与正在进行的EpoKids神经儿科研究并签署书面知情同意;排除标准为既往眼外伤或手术、与早产无关的视网膜或发育疾病。
  • 招募年龄相近的健康对照儿童,纳入标准为足月出生并知情同意,排除标准为任何眼部或视觉异常、高度屈光不正。
  • 检查时检查者与受试者均不知晓干预状态(rhEPO或安慰剂),全部分析完成后检查者才揭盲。

主要发现

  • EPO组(n=52,104眼)与安慰剂组(n=35,70眼)之间ERG参数无差异(校正P均>.05)。
  • 安慰剂组较健康对照(n=52,104眼)两项视锥系统介导的峰值时间略慢(系数0.53,95%CI 0.21-0.85,P=.012;系数0.36,95%CI 0.13-0.60,P=.022)。
  • EPO组较健康对照一项视杆系统为主的峰值时间略快(系数-4.33,95%CI -6.88至-1.78,P=.011)。
  • 次要结局(习惯性视力和色觉辨别表现)在各亚组间相当。

关键数值与推荐

  • 主要结局指标为暗适应和明适应ERG反应振幅与峰值时间(6个振幅、6个峰值时间)。
  • 次要结局为习惯性视力和色觉辨别表现,仅作描述性总结。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the long-term effects of high-dose recombinant human erythropoietin (rhEPO) administered during the perinatal period on retinal and visual function in children born extremely or very preterm. DESIGN: Randomized, double-blind clinical trial follow-up plus cohort study. METHODS: Setting: Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland. STUDY POPULATION: Extremely or very preterm-born children aged 7 to 15 years, previously randomized to receive either high-dose rhEPO or placebo in the perinatal period. INCLUSION CRITERIA: participation in an ongoing neuropediatric study (EpoKids), written informed consent. EXCLUSION CRITERIA: previous ocular trauma or surgery; retinal or developmental disease unrelated to prematurity. Healthy control (HC) children of comparable age were recruited. INCLUSION CRITERIA: term birth, informed consent. EXCLUSION CRITERIA: any ocular/visual abnormality, high refractive error. Intervention status (rhEPO/placebo) was unknown to examiners and subjects at examination, with examiners unblinded only after completion of all analyses. OBSERVATION PROCEDURES: The electroretinogram (ERG) was performed with the RETeval device (LKC Technologies, Inc). Ophthalmological and orthoptic examinations excluded comorbidity in the prematurely born cohort and ocular diseases in the HC group. MAIN OUTCOME MEASURES: Scotopic and photopic ERG response amplitudes and peak times (6 amplitudes; 6 peak times). Secondary outcomes were habitual visual acuity and color discrimination performance (for descriptive summary only). RESULTS: No differences in ERG parameters between EPO (n = 52; 104 eyes) and placebo (n = 35; 70 eyes) subgroups were observed (all corrected P > .05). Two cone system-mediated peak times were slightly slower in the placebo than HC (n = 52; 104 eyes) subgroup (coefficient/95% confidence interval = 0.53/0.21-0.85 and 0.36/0.13-0.60; P = .012 and .022); a predominantly rod system-mediated peak time was slightly faster in the EPO than the HC subgroup (coefficient/95% confidence interval = -4.33/-6.88 to -1.78; P = .011). Secondary outcomes were comparable across subgroups. CONCLUSIONS: Administration of high-dose rhEPO to infants born extremely or very preterm during the perinatal period has no measurable effects on retinal function in childhood compared to placebo. Premature birth may cause small, likely clinically insignificant effects on retinal function in childhood, which may be partially mitigated by administration of rhEPO during the perinatal period.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Sisera L, Hanson JVM, Füglistaler J, et al. The Effect of High-Dose Erythropoietin Perinatally on Retinal Function in School-Aged Children Born Extremely or Very Preterm. Am J Ophthalmol. 2024. PMID: 38996833. doi:10.1016/j.ajo.2024.06.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。